Leproust Emily M.'s Form 4 filing
Twist Bioscience Corp (TWST) · filed Aug 27, 2026
- Accession no.
- 0001214659-26-010968
- Filed
- Aug 27, 2026, 4:05 PM ET
- Trade date
- Aug 25, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions. Open-market sales total $6.32M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Leproust Emily M.CIK 0001753655 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 25, 2026 | Common Stock | SSaleDisposed | −12,648 | $150.56 | −$1,904,333.47 | 799,651 | Direct | |
| Aug 25, 2026 | Common Stock | SSaleDisposed | −12,236 | $151.36 | −$1,851,979.78 | 787,415 | Direct | |
| Aug 25, 2026 | Common Stock | SSaleDisposed | −6,412 | $152.75 | −$979,433 | 781,003 | Direct | |
| Aug 25, 2026 | Common Stock | SSaleDisposed | −9,181 | $153.93 | −$1,413,203.79 | 771,822 | Direct | |
| Aug 25, 2026 | Common Stock | SSaleDisposed | −1,093 | $154.45 | −$168,809.48 | 770,729 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.